BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2013
View Archived Issues
New results reported in murine model of spinocerebellar ataxia
Read More
Isis Pharmaceuticals presents phase I data for ISIS-PTP-1BRx
Read More
Preclinical results and initiation of first-in-human trial of ATROSAB
Read More
Preclinical evaluation of miRNA inhibitor in severe PAH
Read More
PsychoGenics and Sunovion Pharmaceuticals expand CNS partnership
Read More
Genmab and ADC Therapeutics collaborate on antibody-drug conjugate
Read More
Genocea Biosciences prepares new vaccines for HSV-2 infection
Read More
First patient dosed in phase III study of Zubsolv for new indication
Read More
Amgen presents phase I results for AMG-181 in patients with Crohn's disease and ulcerative colitis
Read More
Fluvoxamine maleate enters Japanese phase III trial for pediatric OCD
Read More
DaVita and Myriad establish protein biomarker discovery collaboration
Read More
Additive therapy with ESKM leads to complete eradication of tumors in vivo
Read More
WHO issues interim guidance on bedaquiline for pulmonary multidrug-resistant TB
Read More
New EP2 receptor antagonists patented by Bayer
Read More
Civitas Therapeutics receives second Michael J. Fox Foundation grant for CVT-301
Read More
Beta Pharma presents novel HDAC6 inhibitors
Read More
Phenex Pharmaceuticals designs new RORgamma ligands
Read More
iCo Therapeutics completes enrollment in phase II iDEAL trial
Read More
Chinese researchers patent novel alpha1A-adrenoceptor antagonists
Read More
PhaseBio expands clinical development of Vasomera for cardiopulmonary diseases
Read More
Novel PARP-1 inhibitors presented by Chengdu Di'ao Pharmaceutical Group
Read More
MEI Pharma commences phase II trial of pracinostat and Vidaza in frontline MDS
Read More
ViroMed advances in phase II trial of VM-202-DPN
Read More
FDA obtains license from GVK Biosciences for GOSTAR database
Read More
Oxygen Biotherapeutics gives update on Oxycyte
Read More
